Compare ACAD & MCHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACAD | MCHB |
|---|---|---|
| Founded | 1993 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.1B |
| IPO Year | 2000 | N/A |
| Metric | ACAD | MCHB |
|---|---|---|
| Price | $21.84 | $15.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 2 |
| Target Price | ★ $30.55 | $15.75 |
| AVG Volume (30 Days) | ★ 1.3M | 390.4K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 5.53% |
| EPS Growth | ★ 69.12 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $726,437,000.00 | N/A |
| Revenue This Year | $18.80 | $43.32 |
| Revenue Next Year | $11.70 | N/A |
| P/E Ratio | $1,085.00 | ★ $12.70 |
| Revenue Growth | ★ 40.45 | N/A |
| 52 Week Low | $19.69 | $12.82 |
| 52 Week High | $28.35 | $16.03 |
| Indicator | ACAD | MCHB |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 54.89 |
| Support Level | $21.04 | $13.90 |
| Resistance Level | $22.03 | $15.73 |
| Average True Range (ATR) | 0.58 | 0.37 |
| MACD | 0.07 | 0.08 |
| Stochastic Oscillator | 79.63 | 71.72 |
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.
Mechanics Bancorp is an independent, full-service community bank. It provides personal banking, business banking, trust and estate, brokerage and wealth management services. its retail banking products include personal checking, savings, and loan products (including credit card, home equity, home mortgage, and secured/unsecured loans), online banking, and wealth management services (including trust and estate, investment management, and financial planning services). its banking products and services for businesses include business checking and savings accounts, business debit cards, online banking, cash management services, wealth management services, business credit cards, commercial real estate loans, equipment leasing, and loans guaranteed by the Small Business Administration.